These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32430444)

  • 21. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010.
    Imashuku S
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):35-9. PubMed ID: 21088619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report.
    Takahashi M; Makino S; Iizuka H; Noguchi M; Yoshida K
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):681. PubMed ID: 34620104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a screening score for Hemophagocytic Lymphohistiocytosis among pediatric patients with acute infection of Epstein-Barr virus.
    Li X; Yan H; Xiao Z; Luo T; Xie L; Yang Y; Gong L; Tang Z; Huang J; Zhang X; Zheng M; Yao Z; Zang P; Zhu D; Lu X
    Front Immunol; 2022; 13():981251. PubMed ID: 36172365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
    Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
    J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
    Jin Z; Wang Y; Wei N; Wang Z
    Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
    Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emapalumab as a therapeutic intervention for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: A case series.
    Wang W; Yuan X; Yu L; Pei F
    Medicine (Baltimore); 2024 Sep; 103(39):e39880. PubMed ID: 39331881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report.
    Zhu M; Zhang J; Shi Q; Sun X; Wang H; Sun M; Liu Y
    Iran J Immunol; 2023 Dec; 20(4):466-472. PubMed ID: 37873944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression Profile and Clinical Significance of Cytokines and Chemokines in Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis].
    Gao Y; Zheng Y; Zhang WH; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):268-273. PubMed ID: 36765510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus in the central nervous system.
    Magaki S; Ostrzega N; Ho E; Yim C; Wu P; Vinters HV
    Hum Pathol; 2017 Jan; 59():108-112. PubMed ID: 27574808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
    Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monitoring of Epstein-Barr virus-infected cells by flow cytometer permits early diagnosis and evaluation of disease progression in EBV-associated hemophagocytic lymphohistiocytosis].
    Fukuda M; Nishimura R; Araki R; Kuroda R; Mase S; Nakagawa Y; Tone Y; Maeba H; Wada T; Kasahara Y; Yachie A
    Rinsho Ketsueki; 2012 Mar; 53(3):337-41. PubMed ID: 22499051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure.
    Goldstein SL; Yessayan LT; Krallman KA; Collins M; Benoit S; Westover A; Humes HD
    Pediatr Nephrol; 2023 Mar; 38(3):927-931. PubMed ID: 35869162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of plasma proteomic profiles of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and infectious mononucleosis.
    Haruta K; Suzuki T; Yamaguchi M; Fukuda Y; Torii Y; Takahashi Y; Ito Y; Kawada JI
    J Med Virol; 2024 Feb; 96(2):e29450. PubMed ID: 38304956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
    Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
    Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
    [No Abstract]   [Full Text] [Related]  

  • 36. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
    Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
    Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus-triggered secondary hemophagocytic lymphohistiocytosis.
    Imashuku S; Morimoto A; Ishii E
    Acta Paediatr; 2021 Oct; 110(10):2729-2736. PubMed ID: 34096649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis.
    Xu L; Guo X; Guan H
    Int J Lab Hematol; 2022 Feb; 44(1):74-81. PubMed ID: 34709704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
    Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
    Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cord Blood Transplantation Following Reduced-Intensity Conditioning for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis during Systemic Lupus Erythematosus Treatment.
    Kuriyama T; Kawano N; Yamashita K; Kikuchi I
    J Clin Exp Hematop; 2016; 56(2):126-129. PubMed ID: 27980302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.